Accupril Tabs: Nitrosamine impurity
Last updated
Summary
Product
Accupril Tabs
Issue
Health products - Contamination
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Accupril Tabs |
Accupril Tab 10mg |
DIN 01947672 |
Tablet |
QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 10mg |
DY3042, CK5285 |
Accupril Tabs |
Accupril Tab 20mg |
DIN 01947680 |
Tablet |
QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 20mg |
DT9592, CK6258, CK6259 |
Accupril Tabs |
Accupril Tab 40mg |
DIN 01947699 |
Tablet |
QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 40mg |
DT9591, CM2828, CM2829 |
Issue
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
What you should do
- Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.
- Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.
- If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries.
- Report any health product-related side effects or complaints to Health Canada.
Additional information
Previous recalls or alerts
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pfizer Canada ULC.
17300 Trans-Canada Highway,
Kirkland, QC,
H9J 2M5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-64095
Get notified
Receive notifications for new and updated recalls and alerts by category.